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Abstract
Regulatory T cells (Treg) have been shown to restrict vaccine-induced T cell responses in different experimental models. In
these studies CD4+CD25+ Treg were depleted using monoclonal antibodies against CD25, which might also interfere with
CD25 on non-regulatory T cell populations and would have no effect on Foxp3+CD252 Treg. To obtain more insights in the
specific function of Treg during vaccination we used mice that are transgenic for a bacterial artificial chromosome expressing
a diphtheria toxin (DT) receptor-eGFP fusion protein under the control of the foxp3 gene locus (depletion of regulatory T
cell mice; DEREG). As an experimental vaccine-carrier recombinant Bordetella adenylate cyclase toxoid fused with a MHC-
class I-restricted epitope of the circumsporozoite protein (ACT-CSP) of Plasmodium berghei (Pb) was used. ACT-CSP was
shown by us previously to introduce the CD8+ epitope of Pb-CSP into the MHC class I presentation pathway of professional
antigen-presenting cells (APC). Using this system we demonstrate here that the number of CSP-specific T cells increases
when Treg are depleted during prime but also during boost immunization. Importantly, despite this increase of T effector
cells no difference in the number of antigen-specific memory cells was observed.
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Introduction
The liver stage of malaria is an attractive target for vaccination.
During the liver stage sporozoites invade hepatocytes where they
replicate without provoking clinical illness. After the infected
hepatocytes burst, merozoites are released into the blood stream
and infect red blood cells, where they undergo a massive
replication leading to the symptoms of malaria. Infected hepato-
cytes present plasmodial antigens on MHC class I molecules where
they can be recognized by antigen-specific CD8+ T cells [1,2]. A
high level of protection was induced using irradiated sporozoites
[3] IFNc production by these cells is implicated in protection [4,5].
More recently genetically modified sporozoites were used as
vaccines which induce antigen-specific T cells but are not capable
of establishing the infectious cycle [6,7]. P. berghei is a worldwide
employed infection model for malaria in mice. The efficacy of
experimental vaccines can be tested employing infection of BALB/
c mice with P. berghei sporozoites [8]. Here a peptide of the
circumsporozoite protein (CSP) was identified that is presented on
H-2Kd. Thus in this model the number and function of antigen-
specific T cells [9] can be monitored. Up to now several different
methods were used to induce CSP-specific T cells [10]. Some of
these strategies indeed induce promising numbers of CSP-specific
CD8+ T cells but the degree of protection often varies. Up to now
the most promising strategies rely on heterologous prime/boost
immunization [11].
The adenylate cyclase toxoid (ACT) of Bordetella pertussis is
capable of delivering its catalytic domain and inserted cargo CD8+
T cell epitopes into the cytosol of CD11b-expressing professional
antigen-presenting cells. Thus recombinant and detoxified ACT
containing different epitopes was repeatedly used for delivery into
the MHC class I presentation pathway to generate CD8+ T cells
against model antigens [12], which demonstrates the versatility of
this tool as antigen-delivery system. We used recombinant
detoxified ACT containing an epitope of Plasmodium berghei
CSP (ACT-CSP) in other studies to induce high numbers of IFNc
secreting CD8+ T cells, which confer sterile immunity against
sporozoite challenge when combined with a blockade of CTLA-4
or using a heterologous prime/boost approach with CSP-
espressing Salmonella [13].
Regulatory T cells (Treg) were shown to inhibit immune
responses and thereby play a central role in peripheral tolerance.
Treg also attenuate the immune response during infections and
vaccination. In naı¨ve mice CD4+Foxp3+ T cells express CD25.
Thus antibodies against CD25 have been used to deplete
CD4+CD25+ Treg cells [14,15]. Recent studies have shown that
a depletion of CD4+CD25+ Treg by antibodies led to an increased
number of vaccine-induced T cells [16]. Understanding the exact
role of Treg during vaccination is hampered due to the multiple
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effects anti-CD25 might have also on non-regulatory T cells that
express CD25. Until recently no tools were available to selectively
deplete Treg. Thus we employed transgenic mice in which Foxp3
+
Treg can be specifically depleted to study the specific function of
Treg during vaccination against the liver-stage of P. berghei [17].
These mice are transgenic for a bacterial artificial chromosome
expressing a diphtheria toxin (DT) receptor-eGFP fusion protein
under the control of the foxp3 gene locus. This allows a selective
depletion of Foxp3+ Treg by DT injection.
Collectively our data demonstrate that CD4+Foxp3+ Treg
dampen the magnitude of a CSP-specific CD8+ T cell response
that was induced by vaccination during priming and/or boosting.
In addition, we demonstrated that an enhanced number of T
effector cells are not necessarily accompanied by an increased
number of memory T cells.
Materials and Methods
Mice and parasites
Male DEREG-mice [17] were crossed with female Balb/c mice
in the animal facility of the Bernhard Nocht Institute for Tropical
Medicine. The resulting offsprings were typed by PCR and flow
cytometry. In each experiment hemizygotic DEREG mice were
used with sex and age-matched wildtype littermates as controls.
For some experiments we used the F1 generation of male DEREG
mice on BALB/c background and female C57BL/6 wild type
mice (H-2Kb). The resulting F1 generation expresses H-2Kd and
H-2Kb, which allows the simultaneous analysis of T cell responses
against the malaria CSP-epitope (SYIPSAEKI corresponding to
CSP 245–253) and the SIINFEKL epitope of ovalbumin. Animal
maintenance and experimental procedures were all approved by
the the relevant regulatory agency in Germany, the ‘‘Amt fuer
Gesundheit und Verbraucherschutz of the Hansestadt Hamburg’’.
The procedures followed were in accordance with the ethical
standards of the review board of the Bernhard-Nocht-Institute for
Tropical Medicine and the Ethic Comission of the state of
Hamburg as well as the related recommendations of the EU.
For all experiments 6–8 weeks old mice were used. Plasmodium
berghei ANKA was maintained by alternating cyclic passage of the
parasite in Anopheles stephensi mosquitoes and BALB/c mice at
the mosquito colony of the Bernhard Nocht Institute for Tropical
Medicine. Sporozoites were collected by manual dissection of
infected mosquito salivary glands in minimal essential medium
(MEM) 18–21 days after the mosquito had taken an infectious
blood meal.
Depletion of Treg cells
For depletion of Treg cells, DEREG and control mice were
injected i.p. with 1 mg diphtheria toxin (Merck) diluted in
endotoxin-free PBS for three consecutive days, starting on day 1
after prime or boost immunization.
ACT-CSP toxoid construction and purification
The construction of ACT-CSP was described in a previous
study [9]. The amino acid sequence VRVRKNNDDSYIP
SAEKILEFVKQ, which comprises the MHC I epitope SYIP-
SAEKI corresponding to CSP 245–253, was inserted at position
336 into the catalytic domain of the adenylate cyclase of B.
pertussis. The resulting ACT-CSP also includes the OVA-derived
SIINFEKL epitope, presented in the context of H-2Kb (corre-
sponding to residues 257 to 264 from OVA). The detoxified ACT-
CSP was produced in the E. coli strain XL1-Blue (Stratagene)
transformed with the appropriate plasmid construct.
Immunization and challenge
Mice were immunized i.p. with a single dose of 20 mg ACT-
CSP diluted in 200 ml of phosphate buffered saline (PBS) on day 0.
Boost immunization was performed 14 days after prime immu-
nization. Challenge was performed i.v. seven days after prime or
boost immunization using 1000 Pb sporozoites. For experiments
concerning induction of memory responses the challenge was
performed at later time points as indicated. Mice were examined
every day and parasitemia was determined every two days by light
microscopy of blood smears with Wright’s stain (Sigma, Tauf-
kirchen, Germany).
Quantification of liver-stage burden
Quantification of liver-stage parasite burden was performed as
described previously (Mol. Biochem. Parasitol. 2001, 118, p233–
245). Briefly, at 30 h post-challenge, livers were perfused with PBS
and removed. Total RNA was extracted with Trizol (Invitrogen,
Darmstadt, Germany) according to the manufacturers instruc-
tions. RNA was transcribed using random hexamer primer and
RevertAid H minus reverse transcriptase (Thermo Scientific, St.
Leon-Rot, Germany) according to the manufacturers instructions.
The resulting cDNA was amplified using the following primers: 59-
GGATGTATTCGCTTTATTTAATGCTT-39 and 59-
CACGCGTGCAGCCTAGTAT-39 for the detection of 18S
rRNA of PbA. As reference gene mouse GAPDH was amplified
with the primers 59- GGGTGTGAACCACGAGAAAT-39 and
59-CCTTCCACAATGCCAAAGTT-39. Cycling conditions were
as following: 15 min 95uC, 40 cycles at 95uC for 15 s, 50uC for
20 s and 68uC for 20 s. For each cycle a melting curve analysis
was performed with a ramp from 67u to 95uC. The relative
concentration of P. berghei 18S rRNA was determined with the
comparative Ct method (delta delta Ct).
Isolation of splenocytes and PBL
Spleens were removed at the indicated time points and RBCs
were lysed by addition of ammonium chloride. Blood was collected
from the tail vein and RBCs were lysed by addition of ammonium
chloride.
IFNc-ELISPOT
Single cell suspensions (26105/well) were cultivated in Millipore
HTS HA plates coated with anti-mouse IFNc. Cells were
stimulated with 1 mg/ml CSP245–253 peptide and in some
experiments with 0.1 mg OVA 257–264. Supernatants were
removed after 18 hours and the number of IFNc-producing cells
was determined using ELISPOT, as described elsewhere [18].
Antibodies and Avidin-HRP were purchased from BD Pharmin-
gen (Heidelberg, Germany). The synthetic peptides SYIPSAEKI
and SIINFEKL, corresponding to CD8+ T-cell epitopes CSP
245–253 and OVA 257–264 respectively, were obtained from
MWG (Ebersberg, Germany).
Analysis of cytokine production and proliferation
Single-cell suspensions (105 cells/well) were cultivated in 96-well
plates. Cells were stimulated with 0.01 mg/ml SIINFEKL, 0.1 mg/
ml CSP, 3 mg/ml anti-CD3 or medium RPMI as control. After
48 h, supernatants were removed and the IFNc concentration was
determined by indirect sandwich enzyme linked immunosorbent
assay (ELISA). Antibodies and cytokine standard were purchased
from R&D Systems (Wiesbaden, Germany). Proliferation was
analyzed after 24 h by incorporation of [3H] thymidine. There-
fore, cells were pulsed with 0.5 mCi of [3H] thymidine for 6 h.
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Antibodies and flow cytometry
The following antibodies were purchased from BD Pharmingen
(Heidelberg, Germany): APC-, FITC- or PE-labeled rat anti-
mouse IFNc, IL-10, CD4, CD8a, CD25, CD62L, and FITC-
labeled hamster anti-mouse CD69. APC-labeled rat anti-mouse
TNFa, PE-labeled rat anti-mouse IL-2, PE- and FITC-labeled
anti-mouse Foxp3, as well as the appropriate isotype controls were
from eBioscience (San Diego, CA). The frequency of CSP-specific
T cells was determined using an APC-labeled H2-Kd pentamer
loaded with the CSP 245–253 peptide (Proimmune, Oxford, UK).
Figure 1. Kinetics of Treg depletion in DEREG mice. In DEREG mice on BALB/c background Foxp3
+ Treg can be indentified by their eGFP
expression using flow cytometry. The consecutive application of DT i.p. over three days leads to a depletion of eGFP+Foxp3+ Treg within 72 h (A). For
immunization experiments we used an optimized protocol where mice were treated with DT on days +1, +2 and +3. The percentage of CD4+GFP+ Treg
in the blood was measured in two F1 DEREG C57BL/6 x BALB/c mice by flow cytometry at the indicated time points (B). Data is expressed as mean +/
2 SEM in relation to all cells in the lymphocyte gate as defined by the respective forward- and sideward scatter.
doi:10.1371/journal.pone.0104627.g001
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Intracellular Foxp3 staining was performed with the Foxp3
staining set (eBioscience, San Diego CA), according to the
manufacturer’s instructions. Dead cells were excluded by propi-
dium iodide staining. Data were acquired on a FACSCalibur flow
cytometer (Becton Dickinson, Mountain View, CA) and analyzed
with the CellQuest program (Becton Dickinson). Facs plots are
minimally adjusted in brightness and contrast using Adobe
Photoshop CS6 (Adobe Systems, San Jose, CA).
Statistical analysis
Statistical analysis was done with GraphPad PRISM (GraphPad
Software Inc., San Diego, USA). The Student’s t-test was used for
measuring the significance of difference between two distributions.
statistical significance. Multiple groups were compared using a
one-way or two-way analysis of variance (ANOVA). The Mann-
Whitney test and Bonferroni Multiple Comparison test were used
as a post hoc comparison of the ANOVA. For survival analysis we
employed Kaplan-Meier estimator function for lifetime data. If not
otherwise stated, data are expressed as means 6 SD. Statistical
significance was indicated as followed: ****p,0.0001; ***p,
0.001; **p,0.01; *p,0.05.
Results
Kinetics of Treg depletion in DEREG mice
GFP+Foxp3+ Treg can be rapidly depleted in DEREG mice by
i.p. injection of DT. The percentage of CD4+Foxp3+ Treg cells
dropped from approximately 3% to under 1.5% in blood and
spleen when analyzed 12 h after a single i.p. application of DT
(data not shown). We tested several protocols for the depletion of
Treg. Most efficient was a treatment on three consecutive days
[18]. Using this protocol the Treg numbers were significantly
reduced for almost 5 days. Thus we decided to define a protocol
were we inject DT on days +1, +2, +3 (Fig. 1 A, Fig. S1). Using
this schedule Treg were strongly reduced from day +1 to +5 when
the strongest expansion of vaccine-induced T cells could be
expected (Fig. 1 B). Modified schedules i.e. starting from –1 and/
or prolonged depletion do not lead to statistical significant
enhanced T cell responses (data not shown). The number of
eGFP+/Foxp3+ T cells started to increase from days +5 to +6
(Fig. 1 B). On later time points depleted mice have similar
numbers of eGFP+/Foxp3+ Treg compared to DT treated non
transgenic littermates control mice.
Functional analysis of reappearing Treg
After transient depletion of Treg by DT injection GFP
+Foxp3+
Treg cells repopulate depleted mice rapidly (Fig. 1B). Currently it is
not known if this is due to proliferation of remaining Treg, de novo
repopulation by thymic derived Treg or due to conversion of
conventional T cells. However, we were interested if Treg that
repopulate depleted DEREG mice (‘‘new’’ Treg) have the same
regulatory capacity as the initial Treg population. To this end
BALB/c DEREG mice were depleted by three consecutive DT
injections and 30 days after depletion the Treg that repopulated the
animals were sorted by flow cytometry due to their eGFP-
expression. Similarly GFP+ Treg were sorted from untreated
DEREG mice. Spleen cells of untreated mice were stimulated with
anti-CD3 and incubated with different amounts of the initial GFP+
Treg before depletion and the ‘‘new’’ Treg that reappear after
depletion. Both types of Treg exhibited similar suppressive capacity
and inhibited IL-2 production and proliferation (Fig. 2 A). Similar
assays were performed using either the initial Treg purified from F1
DEREG C57BL/66BALB/c mice or those that reappear in these
mice after depletion. Initial Treg or ‘‘new’’ Treg were incubated
with different amounts of spleen cells from OT-1 T cell receptor
transgenic mice, which were subsequently stimulated with
SIINFEKL-peptide. Again, both types of Treg exhibit a strong
suppressive capacity (Fig. 2 B). Thus Treg that repopulate mice
after transient depletion were functional.
Effects of Treg depletion during prime immunization
To analyze the effect of Treg depletion on the efficacy of
immunization, we used an adenylate cyclase toxoid (ACT-CSP)
that carries an insert of the P. berghei CSP-derived CD8+ T cell
epitope SYIPSAEKI presented on H-2Kd (corresponding to
residues 245 to 253 from CSP) and in addition the OVA-derived
SIINFEKL epitope, presented in the context of H-2Kb (corre-
sponding to residues 257 to 264 from OVA) [9,13]. For initial
immunization experiments we used the F1 generation from male
DEREG-mice on C57BL/6 background and female wildtype
BALB/c mice (F1 DEREG). Cells from these mice express the
MHC class I molecule H-2Kb and H-2Kd. This allows the
simultaneous characterization of T cell responses against P.
berghei-CSP (H-2Kd) and the SIINFEKL (H-2Kb) peptide used as
model antigen in various studies. We have previously shown that a
single application of ACT-CSP can induce IFNc producing CSP-
specific CD8+ T cells. However, the number of CSP-specific CD8+
T cells remained under a threshold needed for protection unless it
was combined with a blockade of CTLA-4 [9]. Accordingly, when
F1 wildtype mice were immunized i.p. with ACT-CSP and treated
with DT, an induction of CSP- and SIINFEKL-specific T cells in
spleens was found to produce IFNc upon restimulation with the
respective peptide. However, when F1 DEREG littermates were
immunized and treated with DT a strong increase in IFNc
production was observed (Fig. 3 A). To further evaluate if the
number of CSP-specific CD8+ T cells also increased, we
specifically stained these cells using the MHC-class I multimer
technology and analyzed the CSP-specific T cells subsequently by
flow cytometry. Here we also found that upon depletion of Treg an
increased number of CSP-specific T cells after immunization with
ACT-CSP was induced (Fig. 3 B). Not immunized control mice
shown no increased specific response upon restimulation. (Fig. 3 C
and D). These data show that a transient depletion of Treg
augments the priming of antigen-specific CD8+ T cells.
The observation that a single immunization with ACT-CSP in
combination with the depletion of Treg already induces a high
Figure 2. Treg that repopulated depleted DEREG-mice are functional suppressors. (A) A F1 DEREG C57BL/6 x BALB/c-mouse were depleted
by three consecutive DT injections and 30 days after depletion the Treg that repopulated the animals were sorted by flow cytometry due to their
eGFP-expression (‘‘new’’Treg). Similarly GFP
+Treg were sorted from an untreated F1 DEREG mice. Purity of both Treg preparation was.95%. Naı¨ve
spleen cells were stimulated with anti-CD3 and incubated with different amounts of the initial GFP+Treg (natural Treg, nTreg) before depletion and the
GFP+ ‘‘new’’ Treg that reappear after depletion. After 48 h the supernatants were harvested and IL-2 production was measured by ELISA. The
proliferation of cells was measured by 3H–Thymidin incorporation. Data are expressed as mean +/2 SD. The experiment was repeated twice with
similar results. (B) A similar assay was performed using either the initial Treg purified from F1 DEREG C57BL/66BALB/c mice or those ‘‘new’’ Treg that
reappear in these mice after depletion. Initial Treg or ‘‘new’’ Treg were incubated with different amounts of spleen cells from OT-1 T cell receptor
transgenic mice, which were subsequently stimulated with SIINFEKL-peptide. After 48 h IL-2 production and proliferation of cells was measured. Data
are expressed as mean +/2 SD. The experiment was repeated once with similar results. ***p,0.0001.
doi:10.1371/journal.pone.0104627.g002
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Figure 3. Effect of Treg depletion on the efficacy of a primary immunization. (A) To analyze the effect of Treg depletion on the efficacy of
immunization, we immunized the F1 generation from male DEREG-mice on C57BL/6 background and female wildtype BALB/c mice (F1 DEREG) on
day 0 using i.p. application of 20 mg of an adenylate cyclase toxoid (ACT-CSP) that carries an insert of the P. berghei CSP-derived CD8+ T cell epitope
SYIPSAEKI presented on H-2Kd (corresponding to residues 245 to 253 from CSP) and the OVA-derived SIINFEKL epitope, presented in the context of
H-2Kb (corresponding to residues 257 to 264 from OVA). On day +1, +2, and +3 immunized F1 DEREG and F1 non-transgenic littermates were treated
with DT. On day +7, spleen cells were restimulated with CSP-peptide or OVA-peptide and IFNc production in spot forming units (SFU) was analyzed
using ELISPOT. Data are expressed as mean +/2 SD of 5 mice. This experiment was repeated twice with similar results. (B) Percentage of CD8+CSP+
spleen cells stained using PE-labeled anti-CD8 and APC-labeled MHC-I-pentamer loaded with CSP-peptide to detect CSP-specific CD8+ T cells. The
mean of five immunized F1 DEREG mouse or a F1 non-transgenic littermates is shown. The percentage of CD8+CSP+ T cells is expressed as mean +/2
SD of whole lymphocytes. (C) A similar experiment was performed using again F1 DEREG mice and F1 non-transgenic littermates that were treated on
days +1, +2, and +3 with DT but without previous immunization. Data are expressed as mean +/2 SD of 5 mice. This experiment was repeated once
with similar results. (D) Percentage of CD8+CSP+ spleen cells stained using PE-labeled anti-CD8 and APC-labeled MHC-I-pentamer loaded with CSP-
Regulatory T Cell Response and Liver-Stage Malaria
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number of CSP-specific CD8+ T cells, prompted us to consider
whether this regimen would be capable to induce protection. To
this end BALB/c DEREG mice and their non-transgenic
littermates were immunized with ACT-CSP and treated as
described with DT to deplete Treg. At day 7 post immunization
both groups of mice were challenged with P. berghei sporozoites
(Fig. 4). The course of the infection was analyzed at the indicated
time points. In the DEREG group, a lower increase in the levels of
parasitemia after challenging was observed (Fig. 4 A). No
significant differences in the survival time of the two groups could
be observed. It is noteworthy that a transient depletion of Treg in
DEREG mice without immunization did not influence the
parasitemia (Fig. 4 B).
Due to the very high number of merozoites released by a single
infected hepatocyte, a direct correlation between liver-stage
burden and parasitemia is unlikely. In order to directly compare
the protection induced by vaccination of Treg depleted and not
depleted mice, parasite burden in the liver after challenge with P.
berghei sporozoites was determined using a quantitative PCR
(qPCR) specific for P. berghei 18S rRNA normalized to a murine
peptide to detect CSP-specific CD8+ T cells. The mean of five immunized F1 DEREG mouse or a F1 non-transgenic littermates is shown. The
percentage of CD8+CSP+ T cells is expressed as mean +/2 SD of whole lymphocytes. **, p,0.01.
doi:10.1371/journal.pone.0104627.g003
Figure 4. Treg-depletion during primary immunization confers only a partial protection against challenge with P. berghei
sporozoites. (A) To analyze the effect of Treg depletion on protection DEREG-mice were immunized on day 0 using i.p. application of 20 mg ACT-
CSP. On day +1, +2, and +3 immunized DEREG-mice and non-transgenic littermates were treated with DT. At day 9 post immunization both groups of
mice were challenged with 1000 P. berghei sporozoites i.v. The resulting parasitemia was monitored at the indicated time points. Parasitemia is
expressed as mean +/2 SD of five mice per group. This experiment was repeated twice with similar results. A single application of ACT-CSP to DT-
treated wild type mice delayed the onset of the blood-stage. (B) The transient depletion of Treg in DEREG mice without immunization did not
influence the parasitemia. **, p,0.01.
doi:10.1371/journal.pone.0104627.g004
Regulatory T Cell Response and Liver-Stage Malaria
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housekeeping gene [19]. To this end, DEREG mice and their non-
transgenic littermates mice were immunized once with ACT-CSP
on day –7. DT was applied on days 26, 25 and 24. On day 0
mice were infected with 1000 PbA sporozoites i.v. In order to
prevent contamination of liver tissue with blood-derived P.
berghei, analysis was performed 30 h post-challenge before the
blood stage was established. Despite the limited time for effector
functions CSP-specific CD8+ T cells to counteract infection,
parasite burden in the liver was reduced in Treg depleted mice
compared with not depleted mice (Fig. 5).
Effect of Treg depletion during boost immunization
To analyze the effect of Treg depletion on the efficacy of a boost
immunization, we vaccinated F1 DEREG mice or their non-
transgenic littermates with ACT-CSP on day 0 and day 14. Both
groups of mice were treated on days 15, 16 and 17 with DT. As
expected we observed a depletion of eGFP+ Treg in F1 DEREG
mice but not in non-transgenic littermates (data not shown). Again
we observed a CSP-specific IFNc response in both groups of mice,
although this response was significantly higher in Treg-depleted
mice (Fig. 6). This indicates that a transient depletion of Treg
increases the number of specific T cells during prime immuniza-
tion (Fig. 3A) or boost immunization (Fig. 6).
In order to investigate if Treg depletion during a boost
immunization with ACT-CSP confers protection, we vaccinated
BALB/c DEREG mice or non-transgenic littermates with ACT-
CSP on day 0 and day 14. Both groups of mice were treated on
days 15, 16 and 17 with DT to deplete Treg in DEREG mice.
Seven days after the boost immunization mice were challenged
with P. berghei sporozoites and the resulting parasitemia was
analyzed at the indicated time points. A decrease of parasitemia in
vaccine-boosted DEREG mice was observed in the course of
blood parasitemia on days 7 and 9 after sporozoite challenge
(Fig. 7).
Effect of Treg depletion on CSP-specific memory
responses
To test whether an enhanced T cell response induced by Treg-
depletion during immunization is reflected by an increased
memory response at later time points after immunization, we
analyzed the CSP-specific CD8+ T cell response in the spleen 6
weeks and 9 weeks after immunization of BALB/c DEREG-mice,
respectively (Fig. 8 A and B). Whereas after immunization the
Treg-depleted mice exhibit a significantly increased number of
CSP-specific cells (Fig. 3), this difference vanished at later time
points and no differences between groups were observed anymore
at 6 weeks and 9 weeks after immunization. At these time points,
Treg-depleted and control mice have similar numbers of CSP-
specific T cells. This indicates that Treg-depletion is accompanied
by an increased expansion of antigen-specific T cells but this cell
population contracts at the same rate as in control mice.
Discussion
Recent studies suggest that regulatory T cells (Treg) play a
central role in the control of the magnitude of an immune response
[20]. The modulation of Treg function is an attractive target to
increase the efficacy of vaccines but a prerequisite for clinical
application is the minimization of possible side effects by designing
interventions as specific as possible [21].
Foxp3+ Treg express CD25 constitutively and it was shown that
anti-CD25 treatment deplete Treg [22,23]. Several studies used
anti-CD25 antibodies to study the function of Treg during infection
[15,24–27]. Using this approach it was demonstrated that Treg
limit the efficacy of vaccine-induced T cell responses [16,28,29].
However, this approach lacks some specificity since not all Treg
populations but many non-Treg cell populations express CD25
[20,30]. Especially during P. berghei infection activated CD4+ T
effector cells are CD25+ [18]. Furthermore, the outcome of anti-
CD25 depletion is often incomplete and critically depends on the
respective tissue and the time-point of antibody application [31].
Figure 5. Impact of Treg depletion in parasite burden in the liver. Female Balb/c wild type and DEREG mice were immunized with 20 mg ACT-
CSP i.p. on day –7. DT was applied on days –6, 25 and –4; on day 0 mice were infected with 1000 P. berghei sporozoites i.v. The P. berghei parasite
load in the livers was determined 30 h after infection by qPCR. The expression of P. berghei 18S rRNA relative to mouse GAPDH expression is shown
as mean +/2 SEM of n = 11 wild type mice and n = 7 DEREG mice. Statistical significance was analyzed using the Mann–Whitney test.
doi:10.1371/journal.pone.0104627.g005
Regulatory T Cell Response and Liver-Stage Malaria
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Using the previously described DEREG mouse it is possible to
deplete Foxp3+ Treg at selected time points by DT injection [17].
Upon injection on three consecutive days the vast majority of Treg
cells were depleted although they started to reappear soon after
stopping DT injection. Using this scheme we generated a time
window of 3 to 5 days were the numbers of Treg were significantly
reduced without observing overt pathology. Foxp3+ Treg rapidly
reappear after depletion and these reappearing Treg have a similar
suppressive potential as the initial Treg population. Thus, DEREG-
mice are an ideal model to study the influence of Treg on T cell
Figure 6. Effect of Treg-depletion on the efficacy of a boost immunization. (A) To analyze the effect of Treg depletion on the efficacy of a
boost immunization, we vaccinated F1 DEREG mice or their non-transgenic littermates with ACT-CSP on day 0 and day 14. Both groups of mice were
treated on days 15, 16 and 17 with DT. On day +25, spleen cells were restimulated with CSP-peptide or OVA-peptide and IFNc production in spot
forming units (SFU) was analyzed using ELISPOT. Data are expressed as mean +/2 SD of 5 mice. This experiment was repeated twice with similar
results. *, p,0.05, p,0.01. (B) A similar experiment was performed using as well F1 DEREG mice and F1 non-transgenic littermates that were treated
on days 15, 16 and 17with DT but without previous immunization.
doi:10.1371/journal.pone.0104627.g006
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priming during initial antigen encounter elicited by vaccines,
whereas all subsequent steps will take place in the presence of
functional Treg. In contrast, data on anti-CD25 treatment suggest
a long lasting effect of at least 13 to 20 days and therefore not only
priming but also expansion and contraction will be influenced by
the lack of Treg [31].
We used in the present study ACT-CSP that induces IFNc
producing CD8+ T cells against a single epitope of CSP of Pb [13].
Although CSP induces a good immune response and confers
protection, is also known that in certain models it has a minimal
role in sterile protection, because other antigens are responsible for
the induction of sterile immunity [32,33].
The number and function of these T cells can be analyzed by
MHC-class I multimer technology and ELISPOT, respectively.
Upon depletion of Treg during priming we found a strong
enhanced number of these CSP-specific T cells producing IFNc. It
is noteworthy that at the time point of ex vivo analysis, the Treg
population already had reached its original size and was proven to
be functional. This suggests that the presence of Treg during initial
antigen-encounter limits the number of responding T cells.
Altough Treg depletion exhibited a strong effect on the vaccine-
induced response upon primary vaccination and boost immuni-
zation, the secondary vaccination did not shown an additional
increase in the magnitude of CSP-specific T-cell expansion. The
enhanced number of antigen specific CD8+ T cells after Treg
depletion was only transient, which indicates that the strong
induction of T cells in the absence of Treg is followed by a strong
contraction of the T cell pool in the presence of Treg. Ultimately
no differences in the number of CSP-specific T cells were found in
both groups several weeks after immunization, although in both
groups a significant number of CSP-specific T cells remained
detectable. A transient depletion of Treg during boost immuniza-
tion was also accompanied by an increased number of antigen-
specific T cells. However, very similar to the situation observed
during priming the differences waned when analyzed at later time
points. This result shows that a simple correlation between the
number of antigen-specific T effector that were primed initially
during immunization and the number of remaining memory T
cells does not exist. Hence our data suggest that the efficacy of
vaccines, which are intended to induce memory responses, cannot
be estimated by analyzing the number of T cells that were primed
initially.
Treg were shown to directly interact with DC and to mitigate
their maturation process [34,35]. Previously it was shown that
depletion of Treg in DEREG-mice is accompanied by an increase
of DC with higher costimulatory activity [36]. Thus Treg might
limit the signal strength by preventing maturation of DC, which
subsequently influence the priming of T cells. In this scenario a
depletion of Treg would augment priming of T cells leading to an
increase of T effector cells but a decrease of memory T cells.
However, Treg were also shown to interact with T cells by either
contact-dependent [37,38] or independent mechanisms [39–41].
Hereby they might influence the expansion of T cells. We
observed no increased induction of memory T cells upon depletion
of Treg. If T effector cells and memory T cells develop in parallel
our data would imply that only the size of the T effector cell pool
but not the size of the memory T cell pool is regulated by Treg.
Further studies are needed to pinpoint the exact function of Treg
during priming and expansion on the subsequent development of
T cell subsets. Whatever the exact function might be, our data
have important implications for vaccine development since they
indicate that Treg depletion, although leading to an enhanced
number of short-lived T effector cells, might not be associated with
an enhanced number of long-living T memory cells, which is the
major goal of prophylactic vaccines. Hence, transient inhibition of
Treg function might be more beneficial when a strong but short-
lived immune response is desired for example in therapeutical
vaccinations e.g. against tumours where an immune response
against self-antigens should be elicited [42].
The infection with P. berghei sporozoites is quite a challenge for
the induced immune response. Only very few hepatocytes are
infected and within 48 h a single infected cell may release up to
30,000 merozoites which is sufficient to trigger the blood-stage of
malaria. Thus CD8+ T cells specific for antigen presented on
MHC-I of hepatocytes must find very few infected cells within a
large excess of uninfected cells and combat them in a very narrow
Figure 7. Treg-depletion during boost immunization leads to decreased parasitic burden after challenge with P. berghei sporozoites.
BALB/c DEREG mice or non-transgenic littermates were immunized with ACT-CSP on day 0 and day 14. Both groups of mice were treated on days 15,
16 and 17 with DT. At day +21 mice were challenged i.v. with 1000 P. berghei sporozoites and the resulting parasitemia was analyzed at the indicated
time points. Data are expressed as mean +/2 SD of 5 mice per group. This experiment was repeated twice with similar results. *, p,0.05.
doi:10.1371/journal.pone.0104627.g007
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time-window. This was demonstrated in a study where different
amounts of CSP-specific cells were transferred [43]. Using this
approach a threshold of protection was defined. For sterile
protection against the liver-stage almost 100 to 1000-fold more T
cells were needed in comparison with bacterial or viral infections
of the liver. Therefore the requirements on a protective immune
response in the P. berghei model are very high and probably
higher in comparison to human malaria since here the liver-stage
lasts much longer [44]. Nevertheless we observed a reduced
parasitemia when mice were immunized in the absence of Treg.
Using qPCR to detect P. berghei 18S RNA in the liver 30 h
postchallenge, we found that depletion of Treg during immuniza-
tion was also accompanied by a significant reduction of parasite
burden, which indicates that the increased number of CSP-specific
CD8+ T cells are capable to combat infected hepatocytes.
However, the difference in the parasitemia between immunized
mice that were depleted for Treg or immunized control mice
vanishes when mice were challenged at later time-points (data not
shown). This corroborated our observation that the enhanced
induction of antigen-specific T cells is not accompanied by an
increased level of long-living T cells of a memory subtype.
Mice were challenged at day 7 post-priming or boosting and 3
days after DT injection, a time at which innate immune responses
might still interfere with the infection. Since Treg are known to
suppress innate immunity [45], it is not certain whether the slight
decrease of parasitemia in DEREG mice was due to increased
numbers of CD8+ T cells and the subsequent decrease in liver-
stage burden or due to a more active innate immune response
against the blood-stage. Our data cannot support the notion that
the reduced parasitemia was mediated by CD8+ T cells, because
the numbers of IFNc-producing CD8+ T cells at day 7 post
primary vaccination (Fig. 3) and at day 7 post secondary
vaccination (Fig. 5) were similar. To clarify this, it is important
for further investigations to include a control group with mice
depleted of CD8+ T cells before parasite challenge.
Collectively our results demonstrate that a specific and transient
depletion of Treg could enhance a vaccine induced CD8
+ T cell
response during prime and boost immunization. Importantly, the
Figure 8. Treg-depletion during boost immunization does not affectmemory responses. BALB/c DEREG mice or non-transgenic littermates
were immunized with ACT-CSP on day 0 and day 14. Both groups of mice were treated on days 15, 16 and 17 with DT. Spleen cells of mice were
restimulated with CSP-peptide after (A) 6 weeks, and (B) 9 weeks. The number of IFNc producing T cells in spot forming units (SFU) was analyzed by
ELISPOT. Data are expressed as mean +/2SD of 5 mice per group and time-point. This experiment was repeated once with similar results.
doi:10.1371/journal.pone.0104627.g008
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enhanced expansion of T effector cells after Treg-depletion was not
accompanied by an increased long-lasting memory response,
demonstrating that the design of novel vaccine strategies must not
only be focussed on the optimisation of a strong short term
immune response since this is not necessarily leading to a strong
memory response.
Supporting Information
Figure S1 Kinetics of Treg depletion in DEREG mice.
The consecutive application of DT i.p. in DEREG mice over three
days leads to a depletion of CD4+Foxp3+ Treg within 72 h. Mice
were treated with DT on days +1, +2 and +3. The percentage of
CD4+Foxp3+ Treg in the blood was measured in three F1 DEREG
C57BL/66BALB/c mice by flow cytometry at the indicated time
points. Data is expressed as mean +/2 SEM in relation to all cells
in the lymphocyte gate as defined by the respective forward- and
sideward scatter.
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